Company Filing History:
Years Active: 2022
Title: Chaowu Ai: Innovator in IDO Inhibitor Research
Introduction
Chaowu Ai is a prominent inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of indoleamine-2,3-dioxygenase (IDO) inhibitors. His work is crucial for advancing treatments for diseases associated with IDO-mediated tryptophan metabolic pathways.
Latest Patents
Chaowu Ai holds a patent for an indoleamine-2,3-dioxygenase inhibitor, which includes a preparative method and its applications. The patent describes a compound represented by formula (I) and outlines a pharmaceutical composition containing this compound. This innovation is aimed at preparing drugs that can prevent and/or treat diseases characterized by pathological features of IDO-mediated tryptophan metabolism. He has 1 patent to his name.
Career Highlights
Chaowu Ai is currently associated with Hinova Pharmaceuticals Inc., where he continues to push the boundaries of pharmaceutical research. His work has garnered attention for its potential impact on drug development and therapeutic applications.
Collaborations
Chaowu Ai collaborates with notable colleagues, including Wu Du and Yu Li, who contribute to his research endeavors. Their combined expertise enhances the innovative capacity of their projects.
Conclusion
Chaowu Ai's contributions to the field of IDO inhibitors represent a significant advancement in pharmaceutical science. His innovative work continues to pave the way for new treatments and therapies.